Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?
At a glance
Conditions
NCT03713528
Where you'd take part
This study runs at 10 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Atrium Mercy Hospital
Charlotte, North Carolinano site contact published
Cleveland Clinic Florida
Weston, Floridano site contact published
New York University - Langone
New York, New Yorkno site contact published
Novant Health Charlotte Orthopedic Hospital
Charlotte, North Carolinano site contact published
OrthoCarolina Research Institute/OrthoCarolina
Charlotte, North Carolinano site contact published
Rush University
Chicago, Illinoisno site contact published
University of California, San Francisco
San Francisco, Californiano site contact published
University of Florida
Gainesville, Floridano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Thomas Fehring, MD · PRINCIPAL_INVESTIGATOR · OrthoCarolina Research Institute, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Recurrence of Infection1 year
The primary outcome measured will be the recurrence of infection by the same organism or reinfection with a new organism as determined by the criteria using the International Consensus Meeting on PJI (1 year follow-up).